Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis

Atherosclerosis affects millions of people worldwide. However, the wide variety of limitations in the current therapeutic options leaves much to be desired in future lipid-lowering therapies. For example, although statins, which are the first-line treatment for coronary heart disease (CHD), reduce t...

Descripción completa

Detalles Bibliográficos
Autores principales: Valanti, Eftaxia-Konstantina, Dalakoura-Karagkouni, Katerina, Sanoudou, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313318/
https://www.ncbi.nlm.nih.gov/pubmed/30282955
http://dx.doi.org/10.3390/jpm8040034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313318/
https://www.ncbi.nlm.nih.gov/pubmed/30282955
http://dx.doi.org/10.3390/jpm8040034

Ejemplares similares